116 related articles for article (PubMed ID: 35754942)
1. Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy.
Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK
Struct Chem; 2022; 33(5):1609-1617. PubMed ID: 35754942
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study.
Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK
Struct Chem; 2022; 33(5):1529-1541. PubMed ID: 35345416
[TBL] [Abstract][Full Text] [Related]
3. In-silico screening for identification of potential inhibitors against SARS-CoV-2 transmembrane serine protease 2 (TMPRSS2).
Barge S; Jade D; Gosavi G; Talukdar NC; Borah J
Eur J Pharm Sci; 2021 Jul; 162():105820. PubMed ID: 33775827
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors.
Shakya A; Chikhale RV; Bhat HR; Alasmary FA; Almutairi TM; Ghosh SK; Alhajri HM; Alissa SA; Nagar S; Islam MA
Mol Divers; 2022 Feb; 26(1):265-278. PubMed ID: 33786727
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies.
Chikhale RV; Gupta VK; Eldesoky GE; Wabaidur SM; Patil SA; Islam MA
J Biomol Struct Dyn; 2020 Aug; ():1-16. PubMed ID: 32741259
[TBL] [Abstract][Full Text] [Related]
6. Exploring the phytochemicals of
Gurung AB; Ali MA; Lee J; Aljowaie RM; Almutairi SM
J King Saud Univ Sci; 2022 Aug; 34(6):102155. PubMed ID: 35702062
[No Abstract] [Full Text] [Related]
7. Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection.
Oyedara OO; Agbedahunsi JM; Adeyemi FM; Juárez-Saldivar A; Fadare OA; Adetunji CO; Rivera G
Phytomed Plus; 2021 Nov; 1(4):100135. PubMed ID: 35403085
[TBL] [Abstract][Full Text] [Related]
8. Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by
Bhowmick S; Mistri TK; Khan MR; Patil PC; Busquets R; Ashif Ikbal AM; Choudhury A; Roy DK; Palit P; Saha A
J Biomol Struct Dyn; 2023 Jul; ():1-21. PubMed ID: 37482789
[TBL] [Abstract][Full Text] [Related]
9. Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study.
Mishra A; Kaur U; Singh A
J Biomol Struct Dyn; 2022 Jul; 40(11):5128-5137. PubMed ID: 33382023
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches.
Idris MO; Yekeen AA; Alakanse OS; Durojaye OA
J Biomol Struct Dyn; 2021 Sep; 39(15):5638-5656. PubMed ID: 32672528
[TBL] [Abstract][Full Text] [Related]
11.
Prajapati KS; Singh AK; Kushwaha PP; Shuaib M; Maurya SK; Gupta S; Senapati S; Singh SP; Waseem M; Kumar S
Vegetos; 2023; 36(2):701-720. PubMed ID: 35729946
[TBL] [Abstract][Full Text] [Related]
12. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential Indonesian marine invertebrate bioactive compounds as TMPRSS2 and SARS-CoV-2 Omicron spike protein inhibitors through computational screening.
Rizka Nurcahyaningtyas H; Irene A; Tri Wibowo J; Yunovilsa Putra M; Yanuar A
Arab J Chem; 2023 Sep; 16(9):104984. PubMed ID: 37234226
[TBL] [Abstract][Full Text] [Related]
14. Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19.
Dankwa B; Broni E; Enninful KS; Kwofie SK; Wilson MD
Struct Chem; 2022; 33(6):2221-2241. PubMed ID: 36118173
[TBL] [Abstract][Full Text] [Related]
15. In Silico Identification of New Anti-SARS-CoV-2 Main Protease (M
Onyango H; Odhiambo P; Angwenyi D; Okoth P
J Trop Med; 2022; 2022():3697498. PubMed ID: 36263438
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel potential inhibitors of TMPRSS2 and Mpro of SARS-CoV-2 using E-pharmacophore and docking-based virtual screening combined with molecular dynamic and quantum mechanics.
Mahgoub MA; Alnaem A; Fadlelmola M; Abo-Idris M; Makki AA; Abdelgadir AA; Alzain AA
J Biomol Struct Dyn; 2023; 41(14):6775-6788. PubMed ID: 35997154
[TBL] [Abstract][Full Text] [Related]
17. Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target.
DurdaĞi S
Turk J Biol; 2020; 44(3):185-191. PubMed ID: 32595355
[TBL] [Abstract][Full Text] [Related]
18. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19.
Hu X; Shrimp JH; Guo H; Xu M; Chen CZ; Zhu W; Zakharov AV; Jain S; Shinn P; Simeonov A; Hall MD; Shen M
ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1124-1135. PubMed ID: 34136758
[TBL] [Abstract][Full Text] [Related]
19. Identification of some dietary flavonoids as potential inhibitors of TMPRSS2 through protein-ligand interaction studies and binding free energy calculations.
Varughese JK; J K; S SK; Francis D; L JLK; G AT
Struct Chem; 2022; 33(5):1489-1502. PubMed ID: 35645548
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel TMPRSS2 inhibitors for COVID-19 using
Alzain AA; Elbadwi FA; Alsamani FO
Inform Med Unlocked; 2022; 29():100870. PubMed ID: 35128036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
